To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
VC-backed AbCellera files for IPO on Nasdaq: Reuters
Peter Thiel-backed biotech developer AbCellera Biologics, which partnered with Eli Lilly for its COVID-19 antibody drug, has filed for an initial public offering, reported Reuters.
